H
Hiroaki Shimokawa
Researcher at Tohoku University
Publications - 976
Citations - 56856
Hiroaki Shimokawa is an academic researcher from Tohoku University. The author has contributed to research in topics: Heart failure & Endothelium. The author has an hindex of 111, co-authored 949 publications receiving 48822 citations. Previous affiliations of Hiroaki Shimokawa include University of Nebraska Medical Center & Nagoya University.
Papers
More filters
Journal ArticleDOI
Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans
Hiroaki Shimokawa,Keiko Morikawa +1 more
TL;DR: This brief review summarizes the current knowledge about H( 2)O(2) as an EDHF, with special reference to its production by the endothelium, its action on membrane potentials and its pathophysiological roles.
Journal ArticleDOI
Role of TGF-β in proliferative vitreoretinal diseases and ROCK as a therapeutic target
Takeshi Kita,Yasuaki Hata,Ryoichi Arita,Shuhei Kawahara,Muneki Miura,Shintaro Nakao,Shintaro Nakao,Yasutaka Mochizuki,Hiroshi Enaida,Yoshinobu Goto,Hiroaki Shimokawa,Ali Hafezi-Moghadam,Tatsuro Ishibashi +12 more
TL;DR: In vivo, fasudil significantly inhibited the progression of experimental PVR in rabbit eyes without affecting the viability of retinal cells by electroretinographic and histological analyses, elucidate the critical role of TGF-β in mediating cicatricial contraction in proliferative vitreoretinal diseases.
Journal ArticleDOI
Hydrogen peroxide as an endothelium-derived hyperpolarizing factor.
TL;DR: It is demonstrated that endothelium-derived H2O2, another reactive oxygen species in addition to NO, plays important roles as a redox-signaling molecule to cause vasodilatation as well as cardioprotection.
Journal ArticleDOI
Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue.
TL;DR: This in vitro pilot study prior to in vivo experiments suggests that on-stent cell delivery of EPCs may be novel therapeutic devices for re-endothelialization or endothelium lining or paving at an atherosclerotic arterial wall, resulting in the prevention of on- Stent thrombus formation and in-Stent restenosis, as well as the rapid formation of normal tissue architecture.
Journal ArticleDOI
Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig
TL;DR: The endothelium‐dependent actions of prostacyclin probably reflect activation of adenylate cyclase, and the relaxations induced by prostacyClin or forskolin also had an endothelia‐dependent component in basilar and femoral arteries and in jugular veins of the pig.